Children's age up to 1 year
Daily oral tablet
LCModel Version 6.31 N was used to apply eddy current correction and quantification relative to water
Important: This product is not approved for human consumption and must be used only for authorized scientific and research purposes
In Eli Lillys Phase 3 TRIUMPH-1 trial (NCT05929066), 2,339 adults without diabetes received once-weekly retatrutide at 4 mg, 9 mg, or 12 mg, or placebo, for 80 weeks, with topline results announced in May 2026
[11] The Gut-Skin Axis: A Validated Biological Framework A 2023 review in Nutrients examining the role of probiotics in skin health through the gut-skin axis identified multiple mechanisms through which gut-acting probiotics influence skin outcomes: decreasing oxidative stress, modulating inflammatory cytokine production, and supporting immune responses that govern microbial balance on the skin surface